Nevirapine is a non-nucleoside reverse transcriptase inhibitor commonly used in human immunodeficiency virus-1 multidrug regimens and associated with life-threatening cutaneous reactions. Here, we report the successful use of intravenous immunoglobulin in a pediatric patient with Stevens-Johnson syndrome and highlight the risk of nevirapine usage in human immunodeficiency virus postexposure prophylaxis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1525-1470.2007.00605.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!